Fetal Cells in Maternal Blood: A Comparison of Methods for Cell Isolation and Identification
- 11 February 2005
- journal article
- research article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 20 (2) , 106-112
- https://doi.org/10.1159/000082432
Abstract
A variety of methods have been used to select and identify fetal cells from maternal blood. In this study, a commonly used 3-step selection method is compared with selection directly from whole blood. Identification of fetal origin by XY FISH of male cells was also evaluated. Maternal blood was drawn either before invasive chorion villus sampling (pre-CVS) or after (post-CVS) from women carrying a male fetus. Fetal cells were isolated either by density gradient centrifugation succeeded by CD45/CD14 depletion and CD71-positive selection from CD45/CD14-negative cells, or by CD71-positive selection directly from whole blood. The true origin of fetal cells recovered by the two methods was established by two rounds of XY chromosome FISH in reverse colors, in some instances combined with anti-zeta (zeta) or anti-zeta/anti-gamma (gamma) antibody staining. In blood samples taken post-CVS and enriched by CD71 selection directly from whole blood, fetal cells were identified with a frequency that was almost four orders of magnitude higher than in post-CVS samples enriched by the 3-step method. In blood samples taken pre-CVS and enriched by the 3-step procedure, no fetal cells were identified by reverse color FISH in 371 ml of blood. In similar samples enriched by CD71 selection on whole blood, two fetal cells were identified in 27 ml of blood. Rehybridization with X and Y chromosome probes with reverse colors was necessary to exclude false Y chromosome signals. Not all fetal cells identified by the presence of a true Y chromosome signal stained with anti-zeta antibody. Selection of fetal NRBCs from maternal blood by CD71-positive selection directly from whole blood is superior to density gradient centrifugation succeeded by CD45/CD14 depletion and CD71 selection of CD45/CD14-negative cells. Combining two markers for fetal origin is recommended for unambiguously identifying a cell as fetal.Keywords
This publication has 14 references indexed in Scilit:
- Sensitivity and Specificity of the Identification of Fetal Cells in Maternal Blood by Combined Staining with Antibodies against Beta-, Gamma- and Epsilon-Globin ChainsFetal Diagnosis and Therapy, 2003
- Circulating trophoblast in maternal bloodPrenatal Diagnosis, 2003
- Intact fetal cells in maternal plasma: are they really there?The Lancet, 2003
- Prenatal Diagnosis Using Fetal Cells and Cell-Free Fetal DNA in Maternal Blood: What Is Currently Feasible?Clinical Obstetrics and Gynecology, 2002
- Non-Invasive Fetal Sex Determination on Fetal Erythroblasts from the Maternal Circulation Using Fluorescence in situ HybridisationFetal Diagnosis and Therapy, 2002
- Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniquesClinical Genetics, 2001
- Strategies for Rare-Event Detection: An Approach for Automated Fetal Cell Detection in Maternal BloodAmerican Journal of Human Genetics, 1998
- Diagnosing and preventing inherited disease: Nucleated erythrocytes in maternal blood: quantity and quality of fetal cells in enriched populationsHuman Reproduction, 1995
- Prenatal diagnosis from maternal blood: simultaneous immunophenotyping and FISH of fetal nucleated erythrocytes isolated by negative magnetic cell sorting.Journal of Medical Genetics, 1993
- Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational ageHuman Genetics, 1993